Compare JAZZ & WMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | WMG |
|---|---|---|
| Founded | 2003 | 1929 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 18.0B |
| IPO Year | 2007 | 2005 |
| Metric | JAZZ | WMG |
|---|---|---|
| Price | $247.13 | $25.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | ★ $217.57 | $36.38 |
| AVG Volume (30 Days) | 702.7K | ★ 2.0M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.17 | N/A |
| Revenue | $1,618,693,000.00 | ★ $4,463,000,000.00 |
| Revenue This Year | $6.22 | $7.20 |
| Revenue Next Year | $7.68 | $5.99 |
| P/E Ratio | $35.67 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $112.53 | $23.34 |
| 52 Week High | $265.05 | $35.42 |
| Indicator | JAZZ | WMG |
|---|---|---|
| Relative Strength Index (RSI) | 49.34 | 38.18 |
| Support Level | $222.49 | $23.34 |
| Resistance Level | $250.49 | $29.65 |
| Average True Range (ATR) | 7.19 | 1.19 |
| MACD | -0.96 | -0.10 |
| Stochastic Oscillator | 15.93 | 8.94 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Warner Music is the third-largest of the three major record companies. Recorded music accounts for most of the firm's revenue, with the segment housing notable record labels including Atlantic Records, Warner Records, Elektra Records. Some of the most successful current artists signed to record deals with Warner include Ed Sheeran, Bruno Mars, Cardi B, and Dua Lipa. Warner's remaining revenue comes from its publishing business, where Warner Chappell represents more than 180,000 songwriters and composers, some of whom are also Warner recording artists but many of whom are not recording artists or are attached to other labels. Warner Chappell controls more than 1 million musical compositions. Access Industries controls 98% of Warner's voting rights, while holding a 72% economic interest.